Brazil expands foreign medtech GMP inspections capacity
This article was originally published in SRA
Executive Summary
Brazil's regulatory agency Anvisa is now able to authorize staff of state- or municipal-controlled centers to conduct inspections abroad of import licensees, on behalf of the national healthcare vigilance system (SNVS)1,2.